Britain Researches Weight-Loss Side Effects 26 Times More Than How to Stop
UK searches about the side effects of weight-loss medicines outnumber searches about coming off them by 26.2 to one, and searches about price and buying outnumber them by 14.0 to one. On SEMrush estimates for 2026-09-03, the terms about stopping draw 5,230 searches a month between them, against 137,100 for side effects and 73,100 for price and buying. Four of the five stopping terms are flat or falling. This analysis of public search estimates was compiled by Bolt Pharmacy, a GPhC-registered online pharmacy.
How much does Britain search about stopping these medicines?
An estimated 5,230 searches a month across five terms, four of which are flat or falling and none rising.
Very little, and less than it used to. The five terms in this analysis about coming off treatment draw an estimated 5,230 searches a month combined.
| Search term | Estimated UK searches per month | Direction, last quarter vs first |
|---|---|---|
| coming off mounjaro | 2,400 | falling |
| stopping mounjaro | 1,000 | falling |
| mounjaro withdrawal | 210 | falling |
| stop taking wegovy | 20 | broadly flat |
| mounjaro not working | 1,600 | falling |
Four of the five are flat or falling on the only trend measure this data supports, the direction of the most recent quarter against the first. None is rising.
What is Britain searching about instead?
Side effects (137,100 a month, 26.2x the stopping cluster) and price and buying (73,100, 14.0x).
Side effects, and price.
| Cluster | Estimated UK searches per month | Versus stopping |
|---|---|---|
| Side effects | 137,100 | 26.2x |
| Price and buying | 73,100 | 14.0x |
| Stopping | 5,230 | - |
The side-effects cluster is two terms. The price cluster is four. The stopping cluster is five. So the gap is not an artifact of counting more terms on one side: the smallest cluster by term count is the largest by volume by a wide margin.
A fifth price term, "weight loss injection", was dropped from the cluster because our two data sources disagree about it by 25 times. That exclusion makes the price ratio smaller, not larger.
Why does the gap matter?
Because it shows where public attention sits. It makes no claim about what happens when someone stops, which is a clinical question for a prescriber.
Because it describes where public attention is, and where it is not.
Stopping a course of treatment is a decision most people on these medicines will face at some point, whether by choice, cost or circumstance. The search data suggests it is researched far less than either the risks of starting or the cost of continuing.
This article makes no claim about what happens when someone stops. That is a clinical question, it varies by person, and it belongs with a prescriber rather than a search-volume table. The finding here is narrower and it is about attention: the questions people type are heavily weighted towards getting started and staying on.
Method, and four limits on these figures
SEMrush estimates for 24 hand-picked terms on 2026-09-03, each cross-checked against Google Ads. Modelled, not exhaustive, and volume is not a count of people.
The figures are SEMrush estimates of Google UK monthly search volume for a hand-picked basket of 24 weight-loss terms, retrieved on 2026-09-03. Every term quoted was cross-checked against Google Ads volume and agreed within a factor of two; terms that did not agree are named and excluded.
They are modelled estimates. SEMrush models Google UK volume rather than reporting counts published by Google, so read them as indicative magnitudes and attribute them to SEMrush.
The clusters are hand-picked. They are illustrative of how people phrase these questions, not exhaustive. Every term in every cluster is named above so a reader can judge the selection. "Mounjaro not working" is counted as a stopping term, which is a judgement call; it makes the stopping cluster larger and both ratios smaller.
Volume is not intent. A term's volume includes everyone researching, comparing, reading news or checking a price. It is not a count of people, of patients, or of prescriptions.
Trend is a direction only. There is no month-by-month series here, so no peak month, seasonality or trend shape is claimed.
The analysis contains no patient data and no first-party Bolt figures.
About Bolt Pharmacy
Bolt Pharmacy is a GPhC-registered online pharmacy (registration 9013085) operated by Bolt Healthcare Ltd. Prescribing is provided by AIOS Technology Ltd, which is registered with the Care Quality Commission.
Frequently Asked Questions
How many people search about coming off weight-loss medication in the UK?
SEMrush estimates around 5,230 UK searches a month across five terms about stopping, including "coming off mounjaro" and "stopping mounjaro". These are modelled estimates of Google volume rather than counts of people.
What do people search about most for weight-loss medicines?
Of the clusters measured here, side effects are largest at an estimated 137,100 searches a month, followed by price and buying at 73,100. Stopping is the smallest at 5,230.
Is interest in stopping weight-loss medication growing?
Not on this data. Four of the five stopping terms show a most recent quarter that is flat or lower than their first quarter, and none is rising. The data supports a direction only, not a month-by-month trend.
Does this say anything about what happens if you stop taking these medicines?
No. This is an analysis of what people search for and carries no information about clinical outcomes. Decisions about starting, continuing or stopping a prescription medicine should be made with a prescriber.
